Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis-Reference-Cited by-同舟云学术

Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis

Published:2024-07-23 Issue: Volume: Page:
ISSN:2210-7703
Container-title:International Journal of Clinical Pharmacy
language:en
Short-container-title:Int J Clin Pharm

Author:

Li Wanshu,Yu Yanan,Li Minghui,Fang Qing,jin Xin,Lin Hangjuan^ORCID,Xu Jun

Funder

NINGBO Medical & Health Leading Academic Discipline Project

NINGBO Medical & Health Brand Discipline Project

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11096-024-01778-y.pdf

Reference44 articles.

1. Dressler R, Dryer MM, Coletti C, et al. Altering overuse of cardiac telemetry in non-intensive care unit settings by hardwiring the use of American Heart Association guidelines. JAMA Intern Med. 2014;174(11):1852–4. https://doi.org/10.1001/jamainternmed.2014.4491.

2. Ying J, Li LC, Wu CY, et al. The status of proton pump inhibitor use: a prescription survey of 45 hospitals in China. Rev Esp Enferm Dig. 2019;111(10):738–43. https://doi.org/10.17235/reed.2019.6155/2019.

3. Yu LY, Sun LN, Zhang XH, et al. A review of the novel application and potential adverse effects of proton pump inhibitors. Adv Ther. 2017;34(5):1070–86. https://doi.org/10.1007/s12325-017-0532-9.

4. Maideen NMP. Adverse effects associated with long-term use of proton pump inhibitors. Chonnam Med J. 2023;59(2):115–27. https://doi.org/10.4068/cmj.2023.59.2.115.

5. Targownik LE, Fisher DA, Saini SD. AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review. Gastroenterology. 2022;162(4):1334–42.